The 69 references in paper T. Voznesenskaya G., Т. Вознесенская Г. (2015) “СИНДРОМ АПАТИИ // APATHY SYNDROME” / spz:neicon:nevro:y:2013:i:3:p:4-10

1
Marin R.S. Apathy: a neuropsychiatric syndrome. J. Neuropsychiatry Clin. Neurosci. 1991; 3: 243—54.
(check this in PDF content)
2
Marin R.S. Apathy: concept, cyndrome, neural mechanisms, and treatment. Semin. Clin. Neuropsychiatry. 1996; 1: 304—14.
(check this in PDF content)
3
Marin R.S., Firinciogullari S., Biedrzycki R.C. Group differences in the relationship between apathy and depression. J. Nerv. Ment. Dis. 1994; 182: 235—9.
(check this in PDF content)
4
Ishii Sh., Weintraub N., Mervis J. Apathy: a common Psychiatric syndrom in the elderly. J. Am. Med. Dir. Assoc. 2009; 10: 381—93.
(check this in PDF content)
5
Guimardes H.C., Levy R. Teixeira A.L. et al Neurobiology of apathy in Alzheimer disease Arq. Neuropsiquiatr. 2008; 66: (2B): 436—43.
(check this in PDF content)
6
Holthoff V.A., Beuthien-Baumann B., Kalbe E. et al. Regional cerebral metabolism in early Alzheimer disease with clinically signifi cant apathy or depression. Biol. Psychiatry. 2005; 57 (4): 412—21.
(check this in PDF content)
7
Landes A.M., Sperry S.D., Straus M.E. Prevalence of Apathy, Disphoria, and depression in relation to dementia severity in Alzheimer disease. J. Neuropsychiatry Clin. Neurosci. 2005; 17: 342—9.
(check this in PDF content)
8
Levy R., Dubois B. Apathy and functional anatomy of the prefrontal cortex-basal ganglia circuits. Cerebr. Cortex. 2006; 16:
(check this in PDF content)
9
6—28. 9. Robert P.H., Darcourt G., Koulibali M.P. et al Lack of initiative and interest in Alzheimer disease. Eur. J. Neurol. 2006; 13: 729—35.
(check this in PDF content)
10
Tekin S., Mega M.S., Masterman D.M. et al. Orbitofrontal and anterior cingulate cortex neurofi brillary tangl burden is assotiated with agitation in Alzheimer disease. Ann. Neurol. 2001; 49: 355—61.
(check this in PDF content)
11
Stuss D.T., Van Reekum R., Murphy K.J. Differentiation of states and causes of apathy. In: Borod J.C., ed. The Neuropsychology of emotion. Oxford: Oxford University Press; 2000: 340—63.
(check this in PDF content)
12
Alexopoulos G.S., Bruce M.L., Silbersweig D. et al. Vascular depression: a new view of late-onset depression. Dialog. Clin. Neurosci. Depress. Elderly. 1999; 1 (2): 68—80.
(check this in PDF content)
13
Alexopoulos G.S. Depression in the elderly. Lancet. 2005; 365: 1961—70.
(check this in PDF content)
14
Bonelli R.M., Cummings J.L. Frontal-subcortical circuitry and behavior. Dialog. Clin. Neurosci. Neuropsychiatr. Manifest. Neurodegenerat. Dis. 2007; 9 (2): 141—51.
(check this in PDF content)
15
Fuh J.L., Wang S.J., Cummings J.L. Neuropsychiatric profi les in patients with Alzheimer disease and vascular dementia. J. Neurol. Neurosurg. Psychiatry. 2005; 76 (10): 1337—41.
(check this in PDF content)
16
Starkstein S.E., Fedoroff J.P., Price T.R. et al Apathy following cerebrovascular lesions. Stroke. 1993; 24: 1625—30.
(check this in PDF content)
17
Freels S., Cohen D., Eisdorfer C. еt al. Functional status and clinical fi ndings in patients with Alzheimer disease. J. Gerontol. A Biol. Sci. Med. Sci. 1992; 47: M177—82.
(check this in PDF content)
18
Godinho C., Camozzato A., Kochhann R., Chaves M.L. Association of caregiver demographic variables and perception of neuropsychiatric symptoms of Alzheimer’s disease patients for distress assessed with the Neuropsychiatric Inventory (NPI) Dement. Neuropsychol. 2008; 2 (3): 211—6.
(check this in PDF content)
19
Holtta E.N., Laakkonen M.L., Laurila J.Y. et al Apathy: prevalens: Associated factors, and prognostic value among frail, older inpatients. J. Am. Med. Dir. Assoc. 2012; 13 (6): 541—5.
(check this in PDF content)
20
Mega M.S., Cummings J.L., Fiorelio T., Garnbein J. The spectrum of behavioral changes in Alzheimer disease. Neurology. 1996; 46 (1): 130—5.
(check this in PDF content)
21
Reekum R., Stuss D.T., Ostrander L. Apathy: Why care? J. Neuropsychiatry Clin. Neurosci. 2005; 17: 7—19.
(check this in PDF content)
22
Teng E., Cummings J.L. Behaviour. In: Gauthier S., ed. Clinical diagnosis and management of Alzheimer disease. 3rd ed. Informa UK Limited. 2007: 189—204.
(check this in PDF content)
23
Vilalta-Franch J., Calvo-Perxas L., Carre-Olmo J. et al. Apathy syndrom in AD epidemiology, prevalence, incidence? Hersistence, and risk and mortality factors. J. Alzheimers Dis. 2013; 33 (2): 535—43.
(check this in PDF content)
24
Back C. The cholinergic hypothesis of neuropsychiatric symptoms in AD. Am. J. Geriatr. Psychiatry. 1998; 6 (Suppl. 1): 864—78.
(check this in PDF content)
25
Cummings J.L., Schneider L., Tariot P.N. et al Reduction of behavioral disturbances and caregiver distress by galantamin in patients in Alzheimer disease. Am. J. Psychiatry. 2004; 161: 532—538.
(check this in PDF content)
26
Lavretsky H., Kumar A. Depressive disorders and cerebrovascular disease. In: Chiu E., Ames D., Katona C., eds. Vascular disease and affective disorders. Martin Dunitz. 2002; 9: 127—43.
(check this in PDF content)
27
Burns A., Forstl H. The instisute of psychiatry AD cohort — part 2 B clinicalpatophysiology observation. Int. J. Geriatr. Psychiatry. 1996; 11: 321—7.
(check this in PDF content)
28
Forstl H., Burns A., Levy R. et al. Neuropatological correlates in behavioral disturbances in confi rmd Alzheimer disease. Br. J. Psychiatry. 1993; 163: 364—8.
(check this in PDF content)
29
Cummings J.L. Cognitive and behavioral heterogeneity in Alzheimer disease — seeking the neurobiological basis. Neurobiol. Aging. 2000; 21: 845—61.
(check this in PDF content)
30
Mayberg H.S. Clinical correlates of PET, SPECT identifi ed defects in dementia. J. Clin. Psychiatry. 1994; 55 (11, Suppl.): 12—21.
(check this in PDF content)
31
Mayberg H.S. Positron emission tomography imaging in depression: a neural systems perspective. Neuroimag. Clin. N. Am. 2003; 13: 805—15.
(check this in PDF content)
32
Cerejeira J., Lagarto L., Mukaetova-Ladinska E.B. Behavioral and psychological symptoms of dementia. Front Neurol. 2012; 3: 73.
(check this in PDF content)
33
Kaufer D.L., Cummings J.L., Christine D. Effect of tacrine on behavioral symptoms in Alzheimer disease: an open-label study. J. Geriatr. Psychiatry Neurol. 1996; 9: 1—6.
(check this in PDF content)
34
Cummings J.L., Mega M., Gray K. et al. The neuropsychiatric inventory. Neurology. 1994; 44: 2308—14.
(check this in PDF content)
35
Вознесенская Т.Г., Медведева А.В., Яхно Н.Н. Некогнитивные нейропсихические расстроства при БА и их коррекция противодементными препратами Неврологический журнал. 2010; 15 (4): 18—25.
(check this in PDF content)
36
Dujardin K., Sockeel P., Devos D. et al. Characteristics of Apathy in Parkinson Disease. Mov. Disord. 2007; 22 (6): 778—84.
(check this in PDF content)
37
Henderson M., Mellers J. D. C. Movement Disorders. In: David A.S. et al. Lishman’s organic psychiatry: A textbook of neuropsychiatry. 4th ed. Willey—Blackwell; 2009: 745—813.
(check this in PDF content)
38
Pluck G.C., Broun R.G. Apathy in Parkinsons disease. J. Neurol. Neurosurg. Psychiatry. 2002; 73: 636—42.
(check this in PDF content)
39
Starkstein S.E., Mayberg H.S., Preziosi T.J., Andrezejewski P. et al. Reliability, validity and clinical correlates of apathy in Parkinson Dis. J. Neuropsychiatry Clin. Neurosci. 1992; 4: 134—9.
(check this in PDF content)
40
Mayo N.E., Fellows L.K., Scott S.C. et al. A longitudinal view of apahty and its Impact after stroke. Stroke. 2009; 40: 3299—307.
(check this in PDF content)
41
Apostolova L.G., Cummings J.L. Neuropsychiatric manifestation in MCI a systematic reviw of the literature. Dement. Geriatr. Cogn. Disord. 2008; 25: 115—26.
(check this in PDF content)
42
Teng E., Lu P.H., Cummings J.L. Neuropsychiatric symptoms are associated with progression from MCI to Alzheimer disease. Dement. Geriatr. Cogn. Disord. 2007; 24 (4): 253—9.
(check this in PDF content)
43
Robert P.H., Berr C., Volteau M. et al. Apathy in patients with MCI and the risk of developing dementia of Alzheimer disease a one-year follow-up study. Clin. Neurol. Neurosurg. 2006; 108 (8): 733—6.
(check this in PDF content)
44
Robert P.H., Berr C., Volteau M. et al. Importans of lack of interest in patients with MCI. Am. J. Geriatr. Psychiatry. 2008; 16 (9): 770—6.
(check this in PDF content)
45
Geda Y.E., Roberts R.O., Knopman D.S. et al. The prevalens of neyropsychiatric symptoms in MCI and normal cognitive aging: a population-Baised study. Arch. Gen. Psychiatry. 2008; 65 (10): 1193—6.
(check this in PDF content)
46
Geda Y.E. Alzheimer Association International in Alzheimer Dis. 2010. Abstract 01-05-05 Presented July 11, 2010.
(check this in PDF content)
47
Lyketsos C.G., Lopez O., Jones B. et al. Prevalens of neuropsychiatric symptoms in dementia and MCI: results from the cardiovascular health study. J.A.M.A. 2002; 288 (12): 1475—83.
(check this in PDF content)
48
Lyketsos C.G., Steinberg M., Tschans J.T. et al. Mental and behavioral disturbances in dementia: fi ndigs from the Cache Country Stude on Memory in Aging. Am. J. Psychiatry. 2000; 157 (5): 708—14.
(check this in PDF content)
49
Вознесенская Т.Г. Эмоционально-аффективные и поведенческие нарушения при легких и умеренных когнитивных расстройствах. Опыт применения мемантина. Неврологический журнал. 2009; 14 (3): 49—55.
(check this in PDF content)
50
Robert P.H., Clairet S., Benoit M. et al. The apathy inventory assesment of apathy and awareness in AD., PD and MCI. Int. J. Geriatr. Psychiatry. 2002; 17: 1099—115.
(check this in PDF content)
51
Захаров В.В., Вознесенская Т.Г. Нервно-психические нарушения: диагностические тесты. М.: МЕДпресс-информ; 2013.
(check this in PDF content)
52
Baldwin R.C. Management of affective disorders in cerebrovascular disease. In: Chiu E., Ames D., Katona C., eds. Vascular disease and affective disorders. Martin Dunitz; 2002: 245—65.
(check this in PDF content)
53
Barnhart W.G., Makela E.N., Latocha M.J. SSRI-induced apathy syndrome: a clinical rewiew. J. Psychiatry Proc. 2004; 10: 196, 199.
(check this in PDF content)
54
Левин О.С. Диагностика и лечение деменции в клинической практике. М.: МЕДпресс; 2010.
(check this in PDF content)
55
Федорова Н.В., Никитина А.В. Прамипексол в корекции аффективных нарушений при болезни Паркинсона. Консилиум Медикум. Неврология и ревматология. 2012; 1: 74—9.
(check this in PDF content)
56
Cummings J.L., Mackell J., Kaufer D. Behavioral effects of current Alzheimer’s disease treatments: a descriptive review. Alzheimers Dement. 2008; 4 (1): 49—60.
(check this in PDF content)
57
Daly E.J., Falk W.E., Brown P. Cholinesterase inhibitors for behavioral disturbance in dementia. Cur. Psychiatr. Rep. 2001; 3: 251—8.
(check this in PDF content)
58
Feldman H., Gauthier S., Hecker J., Vellas B. et al. A 24-week, randomised, doubl blind study of donepezil in moderate to severe Alzheimer disease. Neurology. 2001; 57: 613—20.
(check this in PDF content)
59
Francis P.T. Glutamatergic approaches to the treatment of cognitive and behavioural symptoms in Alzheimer disease. Neurodegenerat. Dis. 2008; 5 (3—4): 241—3.
(check this in PDF content)
60
Gauthier S., Feldman H., Hecker J. et al. Effi cacy of donepezil on behavioral symptoms in patient with moderete to severe AD. Int. Psychogeriatr. 2002; 14: 389—404.
(check this in PDF content)
61
Gauthier S., Wirth Y., Mobius H.J. Effects of memantine on behavioural symptoms in Alzheimer disease patients — an analysis of the NPI data of two randomized controlled studies. Int. J. Geriatr. Psychiatry. 2005; 20 (5): 459—64.
(check this in PDF content)
62
Gauthier S., Loft H., Cummings J. Improvement in behavioural symptoms in patients with moderate to severe Alzheimer disease by memantine — a pooled data analysis. Int. J. Geriatr. Psychiatry. 2008; 23 (5): 537—45.
(check this in PDF content)
63
Gauthier S., Cooper, Loft H. Specifi c benefi ts of memantine on behavioural symptoms in patients with moderate to severe AD. Poster J. Alzcheimer Dementia. 2006; 2 (3, Suppl.): S370.
(check this in PDF content)
64
Loy C., Schneider L. Galantamine for Alzheimer disease and MCI. Cochrane Database Syst. Rev. 2006; 1: CD001747.
(check this in PDF content)
65
Tariot P.N., Farlow M.R., Grosberg G.T., Gracham S.M. et al. Memantine treatment in patients with moderate to severe Alzheimer disease already receving donepezil: a randomized controlled trial. J.A.M.A. 2004; 291: 317—24.
(check this in PDF content)
66
Douglas S., James I., Ballard C. Non-pharmacological intervention in dementia. Advanc. Psychiatr. Treat. 2004; 10: 171—7.
(check this in PDF content)
67
Ferrero-Arias J., Goñi-Imízcoz M., González-Bernal J. et al. The effi cacy of nonpharmacological treatment for dementiarelated apathy. Alzheimer Dis. Assoc. Disord. 2011; 25 (3): 213—9.
(check this in PDF content)
68
Hulme C., Wright J., Clocker T. Non-pharmacological apro aches for dementia that informal carers might try or access:a systematic review. Int. Geriatr. Psychiatry. 2010; 25 (7): 756—63.
(check this in PDF content)
69
Brodaty H., Arasaratnam C. Meta-analysis on nonhparmacjljgical interventions for neuropsychiatrric symptoms of dementia. Am. J. Psychiatry. 2012; 169 (9): 946—53.
(check this in PDF content)